邱明宁导师简介(泌尿外科)
邱明宁,男,1986年10月生,70200app永利附属医院泌尿外科研究室,博士,助理研究员。主要研究领域为泌尿系统肿瘤发病机制以及抗肿瘤药物药理学与毒理学,尤其是在一氧化氮供体药物治疗泌尿系统肿瘤的分子机制以及植物源性药物活性成分抗泌尿系统肿瘤机制与毒理学评价方面开展了大量基础研究工作。现为中国毒理学会会员。
近5年承担的课题有广东省自然科学基金,面上项目,2021A1515011389,钙通道TRPML1介导自噬参与苦豆碱诱导膀胱癌细胞周期阻滞的机制研究,2021-01至2023-12,在研,主持。广东省自然科学基金-区域联合基金,2020A1515111051,铜转运酶ATP7B参与苦豆碱降低膀胱癌细胞顺铂耐药性的机制研究,2020-10至2023-09,在研,主持。湛江市科技局, 湛江市科技竞争性项目,2021A05068,苦豆碱通过ATP7B-mTOR-MITF途径介导自噬降低膀胱癌顺铂耐药的机制研究,2021-09至2023-08在研,主持。附属医院高层次人才启动项目,2020-2030年,在研,主持。
发表论文有:1. Qiu Mingning, Shi FY, Dai F, Song RJ, Wang S, You YF, Zhao BY. A reactive oxygen species activation mechanism contributes to Sophoridine-induced apoptosis in rat liver BRL-3A cells. Journal of Ethnopharmacology, 2018;213:376-383. 2.Qiu Mingning, Zhang S, Ke LZ, Tang HC, Zeng X, Liu JJ. JS-K enhances chemosensitivity of prostate cancer cells to Taxol via reactive oxygen species activation. Oncology Letters, 2019, 17(1): 757-764. 3.Qiu Mingning, Liu J, Su YX, Guo R, Zhao BY, Liu JJ. Diosmetin induces apoptosis by downregulating AKT phosphorylation via p53 activation in human renal carcinoma ACHN Cells. Protein and Peptide Letters, 2020, 27(10):1022-1028. 4.Qiu Mingning, Liu J, Su YX, Liu JJ, Wu CC, Zhao BY. Aloperine induces apoptosis by a reactive oxygen species activation mechanism in human ovarian cancer cells. Protein and Peptide Letters, 2020, 27(9): 860-869. 5.Qiu Mingning, Liu J, Feng P, Su YX, Guo R, Shi FY, Wang S, Zhao BY. Cytochrome P450s regulates aloperine-induced pathological changes in mouse liver and kidney. Research in Veterinary Science, 2020, 132: 97-100. 6.Liu J, Zhao YW, Xia J, Qiu Mingning. Matrine induces toxicity in mouse liver cells through an ROS-dependent mechanism. Research in Veterinary Science, 2020, 132(1): 308-311. 7.Qiu Mingning, Yu LM, Liang JL, Xia J, Wang XG, Liu J. Aloperine Prevents Migration, Invasion, and Adhesion by Upregulating TIMP-4 in Human Bladder Cancer Cells. Protein and Peptide Letters, 2023.
五、个人工作和生活照